Esomeprazole and omeprazole could enhance the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in improved adverse effects for instance drowsiness, although the clinical relevance is small in the majority of people – observe the affected individual for adverse effects (e.If affected individual are not able to resume thei